Skip to content
← Lobby register
R
Other

ResMed

🇪🇺 UNITED STATESRegistered 21/12 staff
Disclosed budget
€25,000 — €49,999
Meetings 12mo
2
Policy files
2
Accredited passes
2

Recent meetings

DateCommissioner / CabinetTopicFile
01 Dec 2025
Fausto Matos
Cabinet member
Data legislation and Digital Omnibus
01 Dec 2025
Fausto Matos
Cabinet member
Data legislation and Digital OmnibusSRC
10 Oct 2024
Peter Van Kemseke
Cabinet member
EB SummitSRC
10 Oct 2024
Peter Van Kemseke
Cabinet member
EB Summit
25 Mar 2020
Thierry Breton
Commissioner
Videoconference with CEOs on COVID-19
25 Mar 2020
Ursula von der Leyen
President
Videoconference with CEOs on COVID-19
25 Mar 2020
Ursula von der Leyen
President
Videoconference with CEOs on COVID-19SRC
25 Mar 2020
Thierry Breton
Commissioner
Videoconference with CEOs on COVID-19SRC

Mission & Goals

ResMed (NYSE: RMD, ASX: RMD) manufactures digital health technologies and cloud-connected medical devices transform care for people with sleep apnoea, insomnia, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.

EU Legislative Interests

• Targeted Revision of the Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices (MDR) • Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (GDPR) • Regulation (EU) 2025/327 of the European Parliament and of the Council of 11 February 2025 on the European Health Data Space and amending Directive 2011/24/EU and Regulation (EU) 2024/2847 • European Strategy for Data COM(2020) 66 final • Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence (AI Act) • Clean Industrial Deal • Regulation (EU) 2023/2854 of the European Parliament and of the Council of 13 December 2023 on harmonised rules on fair access to and use of data and amending Regulation (EU) 2017/2394 and Directive (EU) 2020/1828 (Data Act) • Digital Omnibus • Safe Hearts Plan • Healthier Together Initiative • EU Public Procurement Framework

Communication Activities

- Engaging with European Commission officials including Commissioners, cabinet members and services in DGs such as DG Grow, DG Connect and DG Sante; with MEPS and secretariats on committees such as IMCO, SANT, ENVI and ITRE; and with officials in the Working Party on Pharmaceuticals and Medical Devices in the Council of Ministers and Permanent Representations - Attending public hearings and events hosted in the EU institutions related to healthcare and digital policy - Engaging in conferences and policy events

Interests Represented

Promotes their own interests or the collective interests of their members

Member Of

MedTech Europe: https://www.medtecheurope.org/ DIGITALEUROPE: https://www.digitaleurope.org/ European Business Summit https://ebsummits.eu/ EGN https://be.egn.com/

Organisation Members

https://careers.resmed.com/what-we-do/our-global-businesses/

Connected Legislation